A cancer diagnosis can be devastating filled with fear and uncertainty. But for one Baldwinsville family, their cancer ...

Antonious Hazim, MD, shares insights on his journey into oncology, his experiences at the Mayo Clinic, and his ongoing ...

On October 3, 2024, Teva Pharmaceuticals and mAbxience, a Fresenius Kabi majority-owned group, announced a new global licensing agreement for the development of an anti PD-1 oncology biosimilar ...

Johnson & Johnson raised its 2024 profit and sales forecasts following strong sales of its oncology drugs. The healthcare ...

Sanofi and Orano join forces to develop next-generation radioligand medicinesParis, October 17, 2024. Sanofi and Orano Med, a subsidiary of the ...

Fintel reports that on October 14, 2024, Stifel downgraded their outlook for Kura Oncology (NasdaqGS:KURA) from Buy to Hold.

Its opening comes as concerns have mounted over the state of care for cancer patients, with a report presented to the AHS ...

The American Journal of Managed Care provides insights into the latest news and research in managed care across multimedia ...

The oncology landscape is evolving, with a marked rise in cancer incidence among young adults globally. This challenges the traditional view of cancer as primarily an ailment of the elderly. The ...

Two patients reflected on how extraordinary their oncology nurses are — even noting that they forget about their cancer when ...

Bloodanooga is back at the University of Tennessee at Chattanooga on Oct. 29 and 30. Blood Assurance is encouraging students, ...

Targeted Oncology is pleased to announce that this year’s second recipient is an individual who has showcased outstanding leadership and a profound dedication to enhancing cancer care and actively ...